Application 202343

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	JUVISYNC	SIMVASTATIN; SITAGLIPTIN PHOSPHATE	TABLET;ORAL	10MG;EQ 100MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	Yes	No
002	JUVISYNC	SIMVASTATIN; SITAGLIPTIN PHOSPHATE	TABLET;ORAL	20MG;EQ 100MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	Yes	No
003	JUVISYNC	SIMVASTATIN; SITAGLIPTIN PHOSPHATE	TABLET;ORAL	40MG;EQ 100MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	Yes	No
004	JUVISYNC	SIMVASTATIN; SITAGLIPTIN PHOSPHATE	TABLET;ORAL	10MG;EQ 50MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	Yes	No
005	JUVISYNC	SIMVASTATIN; SITAGLIPTIN PHOSPHATE	TABLET;ORAL	20MG;EQ 50MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	Yes	No
006	JUVISYNC	SIMVASTATIN; SITAGLIPTIN PHOSPHATE	TABLET;ORAL	40MG;EQ 50MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	Yes	No